Emergency transformation experience of the laboratory department of a hospital designated for admission of patients with novel coronavirus infection in emergency conversion

• Published in: Zhenduanxue Lilun yu Shijian Vol. 21; no. 2; pp. 184 - 188
• Main Author: MENG Jun, JIN Peipei, CHEN Changqiang, CHEN Jiuming, FAN Zhenjia, CHEN Shikai, DAI Jing, et al
• Format: Journal Article
• Language: Chinese
• Published: Editorial Office of Journal of Diagnostics Concepts & Practice 01.04.2022
• Subjects: novel coronavirus|nucleic acid specimen|department of clinical laboratory|emergency detection
• ISSN: 1671-2870
• DOI: 10.16150/j.1671-2870.2022.02.016

In late February 2021, a round of indigenous novel coronavirus (referred to as COVID-19) infection emerged in Shanghai, making the COVID-19 outbreak shift from regular prevention and control to drastic pandemic prevention and control measures. According to the requirements of the Guidelines for the Organization and Implementation of Regional Novel Coronavirus Nucleic Acid Testing (Third Edition) issued by the National Health and Wellness Commission, medical institutions at all levels with nucleic acid testing capabilities rapidly carried out novel coronavirus nucleic acid testing, which put forward higher requirements for testing and prevention and control for the emergency conversion of non-designated admission hospitals to designated hospitals. As a clinical department with close contact with novel coronavirus testing specimens, the department of clinical laboratory has long working hours and high work intensity, as well as the potential risk of aerosol and contact transmission of clinical routine specimens